Shanthi Marur

5.7k total citations · 4 hit papers
49 papers, 4.2k citations indexed

About

Shanthi Marur is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shanthi Marur has authored 49 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Otorhinolaryngology, 26 papers in Oncology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shanthi Marur's work include Head and Neck Cancer Studies (30 papers), Lung Cancer Treatments and Mutations (11 papers) and Lung Cancer Research Studies (9 papers). Shanthi Marur is often cited by papers focused on Head and Neck Cancer Studies (30 papers), Lung Cancer Treatments and Mutations (11 papers) and Lung Cancer Research Studies (9 papers). Shanthi Marur collaborates with scholars based in United States, Italy and Germany. Shanthi Marur's co-authors include Arlene A. Forastiere, William H. Westra, Gypsyamber DʼSouza, Giuseppe Sanguineti, Christine G. Gourin, Barbara Burtness, Christine H. Chung, Stuart A. Grossman, Xiaobu Ye and Jian Campian and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and The Journal of Urology.

In The Last Decade

Shanthi Marur

48 papers receiving 4.1k citations

Hit Papers

HPV-associated head and neck cancer: a virus-related canc... 2008 2026 2014 2020 2010 2016 2008 2017 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HPV-associated head and neck cancer: a virus-related cancer epidemic
    2010 1.4k citations Shanthi Marur, Gypsyamber DʼSouza et al. The Lancet Oncology profile →
  2. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
    2016 866 citations Shanthi Marur, Arlene A. Forastiere Mayo Clinic Proceedings profile →
  3. Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment
    2008 560 citations Shanthi Marur, Arlene A. Forastiere Mayo Clinic Proceedings profile →
  4. E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group
    2017 317 citations Shanthi Marur, Shuli Li et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanthi Marur United States 21 2.3k 1.4k 1.3k 1.0k 1000 49 4.2k
Mark C. Weissler United States 37 2.3k 1.0× 1.4k 1.0× 1.6k 1.3× 1.0k 1.0× 1.2k 1.2× 148 4.7k
Esther Kim United States 20 2.0k 0.9× 1.1k 0.8× 1.3k 1.0× 737 0.7× 927 0.9× 71 4.1k
I‐How Chen Taiwan 42 2.1k 0.9× 1.4k 1.0× 1.9k 1.6× 744 0.7× 1.5k 1.5× 97 4.9k
Shiang‐Fu Huang Taiwan 40 3.0k 1.3× 1.6k 1.1× 2.3k 1.8× 918 0.9× 1.0k 1.0× 194 5.1k
Jin‐Ching Lin Taiwan 29 2.2k 1.0× 1.8k 1.2× 1.5k 1.2× 908 0.9× 764 0.8× 106 4.0k
Missak Haigentz United States 37 1.7k 0.7× 1.8k 1.2× 1.6k 1.2× 903 0.9× 736 0.7× 121 3.8k
William N. William United States 33 870 0.4× 2.0k 1.4× 901 0.7× 1.5k 1.4× 893 0.9× 109 4.0k
Hung‐Ming Wang Taiwan 41 2.9k 1.2× 1.6k 1.1× 1.9k 1.5× 993 1.0× 870 0.9× 159 4.8k
Marco Merlano Italy 35 1.3k 0.6× 2.2k 1.6× 848 0.7× 1.4k 1.3× 1.3k 1.3× 188 4.6k
Zachary S. Zumsteg United States 32 1.3k 0.6× 982 0.7× 1.1k 0.9× 1.9k 1.9× 455 0.5× 116 3.8k

Countries citing papers authored by Shanthi Marur

Since Specialization
Citations

This map shows the geographic impact of Shanthi Marur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanthi Marur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanthi Marur more than expected).

Fields of papers citing papers by Shanthi Marur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanthi Marur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanthi Marur. The network helps show where Shanthi Marur may publish in the future.

Co-authorship network of co-authors of Shanthi Marur

This figure shows the co-authorship network connecting the top 25 collaborators of Shanthi Marur. A scholar is included among the top collaborators of Shanthi Marur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanthi Marur. Shanthi Marur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marur, Shanthi, Harpreet Singh, Pallavi S. Mishra‐Kalyani, et al.. (2018). FDA analyses of survival in older adults with metastatic non–small cell lung cancer in controlled trials of PD-1/PD-L1 blocking antibodies. Seminars in Oncology. 45(4). 220–225. 66 indexed citations
2.
William, William N., Jennifer Tseng, Shanthi Marur, et al.. (2018). Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma. Oral Oncology. 82. 83–90. 17 indexed citations
3.
Marur, Shanthi, Shuli Li, Anthony J. Cmelak, et al.. (2017). E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group. Journal of Clinical Oncology. 35(5). 490–497. 317 indexed citations breakdown →
4.
Marur, Shanthi & Arlene A. Forastiere. (2016). Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clinic Proceedings. 91(3). 386–396. 866 indexed citations breakdown →
5.
Khan, Zubair, Joel B. Epstein, Shanthi Marur, et al.. (2015). Cetuximab activity in dysplastic lesions of the upper aerodigestive tract. Oral Oncology. 53. 60–66. 9 indexed citations
6.
7.
Sosa, Julie Ann, Rossella Elisei, Barbara Jarząb, et al.. (2013). Randomized Safety and Efficacy Study of Fosbretabulin with Paclitaxel/Carboplatin Against Anaplastic Thyroid Carcinoma. Thyroid. 24(2). 232–240. 116 indexed citations
8.
Tahari, Abdel, Krishna Alluri, Shanthi Marur, et al.. (2013). Addition of 18F-FDG PET/CT to Clinical Assessment Predicts Overall Survival in HNSCC: A Retrospective Analysis with Follow-up for 12 Years. Journal of Nuclear Medicine. 54(12). 2039–2045. 36 indexed citations
9.
Campian, Jian, et al.. (2013). The association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer.. Journal of Clinical Oncology. 31(15_suppl). 6068–6068. 3 indexed citations
10.
Sosa, Julie Ann, Jai Balkissoon, P. Langecker, et al.. (2012). Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer. Surgery. 152(6). 1078–1087. 32 indexed citations
11.
Gourin, Christine G., Arlene A. Forastiere, Giuseppe Sanguineti, et al.. (2011). Volume‐based trends in surgical care of patients with oropharyngeal cancer. The Laryngoscope. 121(4). 738–745. 10 indexed citations
12.
Sanguineti, Giuseppe, Maria Pia Sormani, Shanthi Marur, et al.. (2011). Effect of Radiotherapy and Chemotherapy on the Risk of Mucositis During Intensity-Modulated Radiation Therapy for Oropharyngeal Cancer. International Journal of Radiation Oncology*Biology*Physics. 83(1). 235–242. 69 indexed citations
13.
Gourin, Christine G., Arlene A. Forastiere, Giuseppe Sanguineti, et al.. (2010). Impact of surgeon and hospital volume on short‐term outcomes and cost of laryngeal cancer surgical care. The Laryngoscope. 121(1). 85–90. 48 indexed citations
14.
Marur, Shanthi, Gypsyamber DʼSouza, William H. Westra, & Arlene A. Forastiere. (2010). HPV-associated head and neck cancer: a virus-related cancer epidemic. The Lancet Oncology. 11(8). 781–789. 1390 indexed citations breakdown →
15.
Marur, Shanthi & Arlene A. Forastiere. (2010). Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer. Current Opinion in Oncology. 22(3). 206–211. 22 indexed citations
16.
Ricchetti, Francesco, Binbin Wu, Todd McNutt, et al.. (2010). Volumetric Change of Selected Organs at Risk During IMRT for Oropharyngeal Cancer. International Journal of Radiation Oncology*Biology*Physics. 80(1). 161–168. 44 indexed citations
17.
Marur, Shanthi & Arlene A. Forastiere. (2010). Update on role of chemotherapy in head and neck squamous cell cancer. Indian Journal of Surgical Oncology. 1(2). 85–95. 9 indexed citations
18.
Sanguineti, Giuseppe, Maria Pia Sormani, G. Brandon Gunn, et al.. (2010). Effect of Radiotherapy and Chemotherapy on the Risk of Mucositis during IMRT for Oropharyngeal Cancer. International Journal of Radiation Oncology*Biology*Physics. 78(3). S471–S471.
19.
Marur, Shanthi & Arlene A. Forastiere. (2008). Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment. Mayo Clinic Proceedings. 83(4). 489–501. 560 indexed citations breakdown →
20.
Marur, Shanthi, James F. Eliason, Lance K. Heilbrun, et al.. (2008). Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma. Urology. 72(4). 898–902. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark C. Weissler Breakdown of academic impact, for papers by Esther Kim Breakdown of academic impact, for papers by I‐How Chen Breakdown of academic impact, for papers by Shiang‐Fu Huang Breakdown of academic impact, for papers by Jin‐Ching Lin Breakdown of academic impact, for papers by Missak Haigentz Breakdown of academic impact, for papers by William N. William Breakdown of academic impact, for papers by Hung‐Ming Wang Breakdown of academic impact, for papers by Marco Merlano Breakdown of academic impact, for papers by Zachary S. Zumsteg
Rankless by CCL
2026